Synim Remedies Private Limited, a active private limited company, was established on 17 March 2017 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239TG2017PTC115968. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sambu Murali Krishna (Director), Juturi Guru Swamy (Director), Siddam Meghana (Director). Past directors included Nageswara Rao Nagasamudram. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12-1-485/24/7/G1&G2,Dhana Lakshmi Nagar,Rd No:1, Indra Prasta Colony,Near Nagole,L B Naga, R,, Hyderabad, Telangana, 500068.
U24239TG2017PTC115968
115968
17 March 2017
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Synim Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sambu Murali Krishna | Director | 20 Jul 2021 | Current |
| Juturi Guru Swamy | Director | 20 Jul 2021 | Current |
| Siddam Meghana | Director | 20 Jul 2021 | Current |
| Juturi Shanthi Lakshmi | Director | 20 Jul 2021 | Current |
| Venkata Vishnu Swetha Darisi | Director | 20 Jul 2021 | Current |
| Latha Sambu | Director | 20 Jul 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Jul 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synim Remedies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 45.2% increase. The company also saw a slight improvement in profitability, with a 9.64% increase in profit. The company's net worth Soared by an impressive increase of 86.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Synim Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Synim Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synim Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synim Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Synim Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Synim Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Sambu Murali Krishna was appointed as a Director was appointed as a Director on 20 Jul 2021 & has been associated with this company since 4 years 5 months . was documented.
Juturi Guru Swamy was appointed as a Director was appointed as a Director on 20 Jul 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
The activity Siddam Meghana was appointed as a Director was appointed as a Director on 20 Jul 2021 & has been associated with this company since 4 years 5 months . was completed.
Progress on Juturi Shanthi Lakshmi was appointed as a Director was appointed as a Director on 20 Jul 2021 & has been associated with this company since 4 years 5 months . was documented.
The CIN of Synim Remedies Private Limited is U24239TG2017PTC115968.
Synim Remedies Private Limited is headquartered at 12-1-485/24/7/G1&G2,Dhana Lakshmi Nagar,Rd No:1, Indra Prasta Colony,Near Nagole,L B Naga, R,, Hyderabad, Telangana, 500068.
Synim Remedies Private Limited was incorporated on 17 March 2017.
The current directors of Synim Remedies Private Limited are
The primary industry of Synim Remedies Private Limited is Trade.
Synim Remedies Private Limited is unlisted.
The authorized capital of Synim Remedies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Synim Remedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX